Seeking Alpha

The Supreme Court unanimously rejects Nestle's (NSRGY.PK) Prometheus Labs request for two...

The Supreme Court unanimously rejects Nestle's (NSRGY.PK) Prometheus Labs request for two patents for a test that enables doctors to set drug dosages for patients with Crohn's disease. The justices explained that the IP was invalid, as it makes claims on laws of nature, which can't be patented.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector